英硅智能公布2026上半年业绩,过亿美元营收验证商业化路径

美通社
Aug 26

上海2026年8月26日 /美通社/ -- 由生成式人工智能(AI)驱动的临床阶段药物研发科技公司英硅智能(Insilico Medicine,HKEX:3696)于近日发布2026年度中期业绩报告。报告显示,公司2026年上半年实现总营收106.3百万美元,同比大幅增长287.2%,毛利率达90.3%;期内,公司实现净利润35.54百万美元,经调整净利润51.23百万美元,经营现金流转正。截至6...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10